*MONEY TIMES TALK*
_May 29, 2021_
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
_May 29, 2021_
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
*Jayant Organics’* Q4 EPS was fairly good at Rs. 6.48 v/s Rs. 2.52 and FY21 EPS of Rs. 11.20 v/s loss of Rs. 8.55 per share points to much better times ahead. Add.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Jindal SAW* declared highest ever quarterly sales and 461% higher net profit. It reduced debt in FY21 and interest cost fell to the lowest since FY14. This dark horse can give multi-bagger returns.
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 200 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 200 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
🎯 Join us 🎯
📢 If stock markets excite you, install Telegram app on your mobile/desktop and join our two Telegram Channels
➡️ @TELEGRAM
➡️https://t.me/marketswizard
👆 *Learning and earning group*
➡️https://t.me/BooksMakeIndiaRead
👆 *Knowledge Enhancement Group*
➡️ @FACEBOOK
https://www.facebook.com/groups/477543072412657/?ref=share
👆 *You can follow us on Facebook also*
➡️ @TWITTER
You can follow us at (@shrey9341): https://twitter.com/shrey9341?s=09
👆 *You can follow us on Twitter also*
📢 If stock markets excite you, install Telegram app on your mobile/desktop and join our two Telegram Channels
➡️ @TELEGRAM
➡️https://t.me/marketswizard
👆 *Learning and earning group*
➡️https://t.me/BooksMakeIndiaRead
👆 *Knowledge Enhancement Group*
➡️ @FACEBOOK
https://www.facebook.com/groups/477543072412657/?ref=share
👆 *You can follow us on Facebook also*
➡️ @TWITTER
You can follow us at (@shrey9341): https://twitter.com/shrey9341?s=09
👆 *You can follow us on Twitter also*
Telegram
Market Wizard
FREE FINANCIAL EDUCATIONAL CHANNEL
Disclaimer : We are not SEBI Registered. Please consult your financial advisor before investing.
All the posts appearing in the channel are only for educational and informational purposes.
ALL RIGHTS RESERVED!!!
Disclaimer : We are not SEBI Registered. Please consult your financial advisor before investing.
All the posts appearing in the channel are only for educational and informational purposes.
ALL RIGHTS RESERVED!!!
🎯🎯🎯
📢 MARKET WIZARD QUARTERLY / YEARLY SUBSCRIPTION PLAN
📢 WE PROVIDE EQUITY CASH AND F&O ALL UNDER ONE PLAN
✒️ 1000/MONTHLY
✒️ 3000/3MONTH
✒️ 10000/YEARLY
🎯 FOLLOWING TYPES OF CALLS WILL BE GIVEN HERE
🚀 INTRADAY
🚀 SHORT TERM & MEDIUM TERM
🚀 POSITIONAL
🚀 LONG TERM OR DELIVERY
🚀 FUTURES & OPTIONS
🚀 SIP STOCKS
🚀 BTST CALLS
📢 CALLS WILL BE FROM MARKET CAPS
👉 LARGE CAP
👉 MID CAP
👉 SMALL CAP
🎯 ALL SEGMENT'S RECCOMONDATION IN ONE ROOF
🎯 MANDETORY TO ALL WHO WANT AVAIL SUBSCRIPTION FILL BELOW FORM AND SUBMIT IT
https://docs.google.com/forms/d/e/1FAIpQLSed5g8JiIGlttu3IUlkJwnCdEMzv-1Z_hr3ylfU55pepmCb6A/viewform?usp=sf_link
👉 TO AVAIL THIS SUBSCRIPTION & MORE DETAILS.
📢 CONTACT BELOW
➡️ Jimit Parekh Sir : +91 9821722433
➡️ Darpan Solanki Sir : +91 9924832776
➡️ Divesh Jain Sir: +91 9870736813
☑️ NOTE :- ENTRY AND EXIT SHOULD BE TAKEN BY MEMBERS CHOICE
⛔ DISCLAIMER :-
WE ARE NOT SEBI REGISTERED
⛔ TRADE AT UR OWN RISK
📢 MARKET WIZARD QUARTERLY / YEARLY SUBSCRIPTION PLAN
📢 WE PROVIDE EQUITY CASH AND F&O ALL UNDER ONE PLAN
✒️ 1000/MONTHLY
✒️ 3000/3MONTH
✒️ 10000/YEARLY
🎯 FOLLOWING TYPES OF CALLS WILL BE GIVEN HERE
🚀 INTRADAY
🚀 SHORT TERM & MEDIUM TERM
🚀 POSITIONAL
🚀 LONG TERM OR DELIVERY
🚀 FUTURES & OPTIONS
🚀 SIP STOCKS
🚀 BTST CALLS
📢 CALLS WILL BE FROM MARKET CAPS
👉 LARGE CAP
👉 MID CAP
👉 SMALL CAP
🎯 ALL SEGMENT'S RECCOMONDATION IN ONE ROOF
🎯 MANDETORY TO ALL WHO WANT AVAIL SUBSCRIPTION FILL BELOW FORM AND SUBMIT IT
https://docs.google.com/forms/d/e/1FAIpQLSed5g8JiIGlttu3IUlkJwnCdEMzv-1Z_hr3ylfU55pepmCb6A/viewform?usp=sf_link
👉 TO AVAIL THIS SUBSCRIPTION & MORE DETAILS.
📢 CONTACT BELOW
➡️ Jimit Parekh Sir : +91 9821722433
➡️ Darpan Solanki Sir : +91 9924832776
➡️ Divesh Jain Sir: +91 9870736813
☑️ NOTE :- ENTRY AND EXIT SHOULD BE TAKEN BY MEMBERS CHOICE
⛔ DISCLAIMER :-
WE ARE NOT SEBI REGISTERED
⛔ TRADE AT UR OWN RISK
Google Docs
MARKET WIZARD PREMIUM
🔴Rules & Disclaimers
📢PLS READ IT VERY CAREFULLY BEFORE AGREEING
1️⃣No phone calls or personal message to the admins.
2️⃣No chit-chat shall be entertained in the group.
3️⃣No sure shot on any views.
4️⃣Profit / loss not guaranteed.
5️⃣Those who want…
📢PLS READ IT VERY CAREFULLY BEFORE AGREEING
1️⃣No phone calls or personal message to the admins.
2️⃣No chit-chat shall be entertained in the group.
3️⃣No sure shot on any views.
4️⃣Profit / loss not guaranteed.
5️⃣Those who want…
MARKET WIZARD NEWSLETTER ISSUE 12.pdf
2 MB
MARKET WIZARD NEWSLETTER ISSUE 12.pdf
🎯MARKET WIZARD🎯
📊 NEWSLETTER ISSUE 12
🎯 *Fundamental Stocks*
▶️Nelcast Ltd
▶️D B Corp Ltd
▶️Reliance Industries Ltd
▶️ITC Industrial Ltd
▶️BCG Ltd
🎯 *Technical Stocks*
▶️Arvind Fashion Ltd
▶️ *BBTC Ltd - SPECIAL PICK*
▶️ INTENSE TECH Ltd
▶️ KIRI INDUSTRIES Ltd
▶️ TOKYO PLAST Ltd
📍TEAM MARKET WIZARD📍
📊 NEWSLETTER ISSUE 12
🎯 *Fundamental Stocks*
▶️Nelcast Ltd
▶️D B Corp Ltd
▶️Reliance Industries Ltd
▶️ITC Industrial Ltd
▶️BCG Ltd
🎯 *Technical Stocks*
▶️Arvind Fashion Ltd
▶️ *BBTC Ltd - SPECIAL PICK*
▶️ INTENSE TECH Ltd
▶️ KIRI INDUSTRIES Ltd
▶️ TOKYO PLAST Ltd
📍TEAM MARKET WIZARD📍
Good Afternoon Members
Market Wizard is trying to help each of our members... Whether Premium Members or Public Members and we aim at solving queries of everyone
However, members are failing to understand that an admin has to respond to more than 10000 members and they do have some personal life and personal work
It is observed that members are expecting spoon feeding for each call given... message are being sent in Personal for entry and exit despite everything mentioned in the calls
It is also observed that when the Admin do not respond to the queries for sometime, continuous calls are being made
Members have been calling and asking the admin to send the Newsletter to them personally or send them every week to their email id.
Members please understand...Stop Calling us for everything...We can't do spoon feeding.You all are in stock market and putting in your hard earned money...so please put some efforts and don't expect spoon feeding
If such calls keep on flowing continuously, that member shall be removed from the group, even if he is a Premium Members
Market Wizard is trying to help each of our members... Whether Premium Members or Public Members and we aim at solving queries of everyone
However, members are failing to understand that an admin has to respond to more than 10000 members and they do have some personal life and personal work
It is observed that members are expecting spoon feeding for each call given... message are being sent in Personal for entry and exit despite everything mentioned in the calls
It is also observed that when the Admin do not respond to the queries for sometime, continuous calls are being made
Members have been calling and asking the admin to send the Newsletter to them personally or send them every week to their email id.
Members please understand...Stop Calling us for everything...We can't do spoon feeding.You all are in stock market and putting in your hard earned money...so please put some efforts and don't expect spoon feeding
If such calls keep on flowing continuously, that member shall be removed from the group, even if he is a Premium Members
Follow this link to join my WhatsApp group: https://chat.whatsapp.com/KUuI70RifSW7chXFiwwAMY
Result Highlights
Mahindra & Mahindra Ltd.: Net Revenue at Rs. 21456.0 crore, +31.5% YoY and -0.8% QoQ. EBITDA at Rs. 3884.3 crore, +41.6% YoY and +10.3% QoQ. EBITDA Margin at 18.1%, +129 bps YoY and +182 bps QoQ. Net Profit at Rs. 1634.9 crore vs loss of Rs. 588.1 crore YoY and +41.2% QoQ.
3M India Ltd.: Net Revenue at Rs. 827.1 crore, +22.9% YoY and +11.5% QoQ. EBITDA at Rs. 102.3 crore, +34% YoY and +11.6% QoQ. EBITDA Margin at 12.4%, +103 bps YoY and +1 bps QoQ. Net Profit at Rs. 70.5 crore, +17.2% YoY and +18.7% QoQ.
Sundaram Finance Ltd.: Net Revenue at Rs. 1285.0 crore, -2.7% YoY and -7.7% QoQ. Net Profit at Rs. 299.4 crore, +38.8% YoY and -17.7% QoQ.
REC Ltd.: Net Revenue at Rs. 9211.5 crore, +19.3% YoY and +1.4% QoQ. Net Profit at Rs. 2077.8 crore, +338.4% YoY and -8% QoQ.
Ipca Laboratories Ltd.: Net Revenue at Rs. 1114.7 crore, +3.8% YoY and -20.9% QoQ. EBITDA at Rs. 228.9 crore, +35.9% YoY and -37.6% QoQ. EBITDA Margin at 20.5%, +485 bps YoY and +-549 bps QoQ. Net Profit at Rs. 161.2 crore, +94.1% YoY and -39.8% QoQ.
Max Healthcare Institute Ltd.: Net Revenue at Rs. 801.9 crore, +223.5% YoY and +0.8% QoQ. EBITDA at Rs. 168.1 crore, +754.9% YoY and +5% QoQ. EBITDA Margin at 21%, +1303 bps YoY and +83 bps QoQ. Net Profit at Rs. 69.7 crore, +31.1% YoY and -22.9% QoQ.
Sumitomo Chemical India Ltd.: Net Revenue at Rs. 534.3 crore, +19.6% YoY and -4.7% QoQ. EBITDA at Rs. 71.3 crore, +72.2% YoY and -8.6% QoQ. EBITDA Margin at 13.4%, +408 bps YoY and +-56 bps QoQ. Net Profit at Rs. 54.1 crore, +136.2% YoY and -0.1% QoQ.
Glenmark Pharmaceuticals Ltd.: Net Revenue at Rs. 2859.9 crore, +3.3% YoY and +2.6% QoQ. EBITDA at Rs. 523.4 crore, +12.4% YoY and -1.3% QoQ. EBITDA Margin at 18.3%, +147 bps YoY and +-72 bps QoQ. Net Profit at Rs. 233.9 crore, +6.2% YoY and -5.8% QoQ.
Indian Bank: NII at Rs. 3334.3 crore, +66.5% YoY and -22.7% QoQ. Net Profit at Rs. 1708.9 crore vs loss of Rs. 217.4 crore YoY and +232.3% QoQ. GNPA at 9.85%, Vs 6.87% YoY and 9.04% QoQ. NNPA at 3.37%, Vs 3.13% YoY and 2.35% QoQ.
City Union Bank Ltd.: NII at Rs. 428.5 crore, +2.2% YoY and -12.4% QoQ. Net Profit at Rs. 111.2 crore vs loss of Rs. 95.3 crore YoY and -34.6% QoQ. GNPA at 5.11x, Vs 4.09x YoY and 2.94x QoQ. NNPA at 2.97x, Vs 2.29x YoY and 1.47x QoQ.
Dilip Buildcon Ltd.: Net Revenue at Rs. 3135.5 crore, +14.9% YoY and +14.2% QoQ. EBITDA at Rs. 584.3 crore, +0.5% YoY and -7.3% QoQ. EBITDA Margin at 18.6%, -266 bps YoY and -432 bps QoQ. Net Profit at Rs. 186.2 crore, -2.6% YoY and +2.2% QoQ.
GMM Pfaudler Ltd.: Net Revenue at Rs. 458.6 crore, +248% YoY and +127.2% QoQ. EBITDA at Rs. 29.8 crore, +32.5% YoY and -29% QoQ. EBITDA Margin at 6.5%, -1056 bps YoY and -1429 bps QoQ. Net Profit at Rs. -5.8 crore, -149.6% YoY and -124.9% QoQ.
V-Mart Retail Ltd.: Net Revenue at Rs. 351.9 crore, +5.8% YoY and -25.1% QoQ. EBITDA at Rs. 33.6 crore, +20.5% YoY and -67.7% QoQ. EBITDA Margin at 9.5%, +117 bps YoY and +-1255 bps QoQ. Net Loss at Rs. 1.5 crore vs loss of Rs. 8.4 crore YoY and Profit of Rs. 47.9 crore QoQ.
Heidelberg Cement India Ltd.: Net Revenue at Rs. 600.0 crore, +17.7% YoY and +0.8% QoQ. EBITDA at Rs. 152.2 crore, +19.5% YoY and +26.6% QoQ. EBITDA Margin at 25.4%, +38 bps YoY and +517 bps QoQ. Net Profit at Rs. 140.0 crore, +111.2% YoY and +120% QoQ.
Nazara Technologies Ltd.: Net Revenue at Rs. 123.4 crore, +41.7% YoY and -5.4% QoQ. EBITDA at Rs. 9.3 crore, +1883.2% YoY and -63.6% QoQ. EBITDA Margin at 7.6%, +701 bps YoY and +-1209 bps QoQ. Net Profit at Rs. 4.2 crore vs loss of Rs. 7.0 crore YoY and -76.3% QoQ.
NCC Ltd.: Net Revenue at Rs. 2816.6 crore, +20.7% YoY and +32.4% QoQ. EBITDA at Rs. 305.7 crore, +6.5% YoY and +19.3% QoQ. EBITDA Margin at 10.9%, -144 bps YoY and -119 bps QoQ. Net Profit at Rs. 118.5 crore, +95.6% YoY and +52.1% QoQ.
Karur Vysya Bank Ltd.: NII at Rs. 612.6 crore, +3.7% YoY and +5% QoQ. Net Profit at Rs. 104.4 crore, +24.7% YoY and +201.4% QoQ. GNPA at 7.85x, Vs 8.68x YoY and 7.37x QoQ. NNPA at 3.41x, Vs 3.92x YoY and 2.55x QoQ.
Mahindra & Mahindra Ltd.: Net Revenue at Rs. 21456.0 crore, +31.5% YoY and -0.8% QoQ. EBITDA at Rs. 3884.3 crore, +41.6% YoY and +10.3% QoQ. EBITDA Margin at 18.1%, +129 bps YoY and +182 bps QoQ. Net Profit at Rs. 1634.9 crore vs loss of Rs. 588.1 crore YoY and +41.2% QoQ.
3M India Ltd.: Net Revenue at Rs. 827.1 crore, +22.9% YoY and +11.5% QoQ. EBITDA at Rs. 102.3 crore, +34% YoY and +11.6% QoQ. EBITDA Margin at 12.4%, +103 bps YoY and +1 bps QoQ. Net Profit at Rs. 70.5 crore, +17.2% YoY and +18.7% QoQ.
Sundaram Finance Ltd.: Net Revenue at Rs. 1285.0 crore, -2.7% YoY and -7.7% QoQ. Net Profit at Rs. 299.4 crore, +38.8% YoY and -17.7% QoQ.
REC Ltd.: Net Revenue at Rs. 9211.5 crore, +19.3% YoY and +1.4% QoQ. Net Profit at Rs. 2077.8 crore, +338.4% YoY and -8% QoQ.
Ipca Laboratories Ltd.: Net Revenue at Rs. 1114.7 crore, +3.8% YoY and -20.9% QoQ. EBITDA at Rs. 228.9 crore, +35.9% YoY and -37.6% QoQ. EBITDA Margin at 20.5%, +485 bps YoY and +-549 bps QoQ. Net Profit at Rs. 161.2 crore, +94.1% YoY and -39.8% QoQ.
Max Healthcare Institute Ltd.: Net Revenue at Rs. 801.9 crore, +223.5% YoY and +0.8% QoQ. EBITDA at Rs. 168.1 crore, +754.9% YoY and +5% QoQ. EBITDA Margin at 21%, +1303 bps YoY and +83 bps QoQ. Net Profit at Rs. 69.7 crore, +31.1% YoY and -22.9% QoQ.
Sumitomo Chemical India Ltd.: Net Revenue at Rs. 534.3 crore, +19.6% YoY and -4.7% QoQ. EBITDA at Rs. 71.3 crore, +72.2% YoY and -8.6% QoQ. EBITDA Margin at 13.4%, +408 bps YoY and +-56 bps QoQ. Net Profit at Rs. 54.1 crore, +136.2% YoY and -0.1% QoQ.
Glenmark Pharmaceuticals Ltd.: Net Revenue at Rs. 2859.9 crore, +3.3% YoY and +2.6% QoQ. EBITDA at Rs. 523.4 crore, +12.4% YoY and -1.3% QoQ. EBITDA Margin at 18.3%, +147 bps YoY and +-72 bps QoQ. Net Profit at Rs. 233.9 crore, +6.2% YoY and -5.8% QoQ.
Indian Bank: NII at Rs. 3334.3 crore, +66.5% YoY and -22.7% QoQ. Net Profit at Rs. 1708.9 crore vs loss of Rs. 217.4 crore YoY and +232.3% QoQ. GNPA at 9.85%, Vs 6.87% YoY and 9.04% QoQ. NNPA at 3.37%, Vs 3.13% YoY and 2.35% QoQ.
City Union Bank Ltd.: NII at Rs. 428.5 crore, +2.2% YoY and -12.4% QoQ. Net Profit at Rs. 111.2 crore vs loss of Rs. 95.3 crore YoY and -34.6% QoQ. GNPA at 5.11x, Vs 4.09x YoY and 2.94x QoQ. NNPA at 2.97x, Vs 2.29x YoY and 1.47x QoQ.
Dilip Buildcon Ltd.: Net Revenue at Rs. 3135.5 crore, +14.9% YoY and +14.2% QoQ. EBITDA at Rs. 584.3 crore, +0.5% YoY and -7.3% QoQ. EBITDA Margin at 18.6%, -266 bps YoY and -432 bps QoQ. Net Profit at Rs. 186.2 crore, -2.6% YoY and +2.2% QoQ.
GMM Pfaudler Ltd.: Net Revenue at Rs. 458.6 crore, +248% YoY and +127.2% QoQ. EBITDA at Rs. 29.8 crore, +32.5% YoY and -29% QoQ. EBITDA Margin at 6.5%, -1056 bps YoY and -1429 bps QoQ. Net Profit at Rs. -5.8 crore, -149.6% YoY and -124.9% QoQ.
V-Mart Retail Ltd.: Net Revenue at Rs. 351.9 crore, +5.8% YoY and -25.1% QoQ. EBITDA at Rs. 33.6 crore, +20.5% YoY and -67.7% QoQ. EBITDA Margin at 9.5%, +117 bps YoY and +-1255 bps QoQ. Net Loss at Rs. 1.5 crore vs loss of Rs. 8.4 crore YoY and Profit of Rs. 47.9 crore QoQ.
Heidelberg Cement India Ltd.: Net Revenue at Rs. 600.0 crore, +17.7% YoY and +0.8% QoQ. EBITDA at Rs. 152.2 crore, +19.5% YoY and +26.6% QoQ. EBITDA Margin at 25.4%, +38 bps YoY and +517 bps QoQ. Net Profit at Rs. 140.0 crore, +111.2% YoY and +120% QoQ.
Nazara Technologies Ltd.: Net Revenue at Rs. 123.4 crore, +41.7% YoY and -5.4% QoQ. EBITDA at Rs. 9.3 crore, +1883.2% YoY and -63.6% QoQ. EBITDA Margin at 7.6%, +701 bps YoY and +-1209 bps QoQ. Net Profit at Rs. 4.2 crore vs loss of Rs. 7.0 crore YoY and -76.3% QoQ.
NCC Ltd.: Net Revenue at Rs. 2816.6 crore, +20.7% YoY and +32.4% QoQ. EBITDA at Rs. 305.7 crore, +6.5% YoY and +19.3% QoQ. EBITDA Margin at 10.9%, -144 bps YoY and -119 bps QoQ. Net Profit at Rs. 118.5 crore, +95.6% YoY and +52.1% QoQ.
Karur Vysya Bank Ltd.: NII at Rs. 612.6 crore, +3.7% YoY and +5% QoQ. Net Profit at Rs. 104.4 crore, +24.7% YoY and +201.4% QoQ. GNPA at 7.85x, Vs 8.68x YoY and 7.37x QoQ. NNPA at 3.41x, Vs 3.92x YoY and 2.55x QoQ.
Deepak Fertilisers & Petrochemicals Corporation Ltd.: Net Revenue at Rs. 1575.1 crore, +21.8% YoY and +8.8% QoQ. EBITDA at Rs. 273.1 crore, +128.4% YoY and +26% QoQ. EBITDA Margin at 17.3%, +809 bps YoY and +236 bps QoQ. Net Profit at Rs. 115.8 crore, +414.7% YoY and +30.2% QoQ.
Time Technoplast Ltd.: Net Revenue at Rs. 951.2 crore, +3.8% YoY and +13.9% QoQ. EBITDA at Rs. 129.1 crore, +9.3% YoY and +15% QoQ. EBITDA Margin at 13.6%, +68 bps YoY and +12 bps QoQ. Net Profit at Rs. 51.8 crore, +28.5% YoY and +30% QoQ.
ITD Cementation India Ltd.: Net Revenue at Rs. 983.9 crore, +33% YoY and +24.3% QoQ. EBITDA at Rs. 113.8 crore, +35.2% YoY and +60.4% QoQ. EBITDA Margin at 11.6%, +19 bps YoY and +261 bps QoQ. Net Profit at Rs. 52.6 crore vs loss of Rs. 5.5 crore YoY and +75.2% QoQ.
SMS Pharmaceuticals Ltd.: Net Revenue at Rs. 171.3 crore, +77.6% YoY and +15.1% QoQ. EBITDA at Rs. 41.1 crore, +185% YoY and +19.2% QoQ. EBITDA Margin at 24%, +905 bps YoY and +84 bps QoQ. Net Profit at Rs. 22.2 crore, +255.4% YoY and +21.2% QoQ.
Time Technoplast Ltd.: Net Revenue at Rs. 951.2 crore, +3.8% YoY and +13.9% QoQ. EBITDA at Rs. 129.1 crore, +9.3% YoY and +15% QoQ. EBITDA Margin at 13.6%, +68 bps YoY and +12 bps QoQ. Net Profit at Rs. 51.8 crore, +28.5% YoY and +30% QoQ.
ITD Cementation India Ltd.: Net Revenue at Rs. 983.9 crore, +33% YoY and +24.3% QoQ. EBITDA at Rs. 113.8 crore, +35.2% YoY and +60.4% QoQ. EBITDA Margin at 11.6%, +19 bps YoY and +261 bps QoQ. Net Profit at Rs. 52.6 crore vs loss of Rs. 5.5 crore YoY and +75.2% QoQ.
SMS Pharmaceuticals Ltd.: Net Revenue at Rs. 171.3 crore, +77.6% YoY and +15.1% QoQ. EBITDA at Rs. 41.1 crore, +185% YoY and +19.2% QoQ. EBITDA Margin at 24%, +905 bps YoY and +84 bps QoQ. Net Profit at Rs. 22.2 crore, +255.4% YoY and +21.2% QoQ.
*M&M Lines Up Rs 12,000 Crore To Revamp Vehicles, Regain Market Share*
Mahindra & Mahindra Ltd. will spend Rs 12,000 crore in the next three years towards launching and upgrading a range of passenger and commercial vehicles as it seeks to regain lost market share.
The capex earmarked will fuel the company’s plan of launching 23 new products in commercial and passenger vehicle segments in the next five years, Chief Financial Officer Manoj Bhat said on a call with analysts on May 28 after the company announced quarterly earnings. Once a market leader in the SUV segment, M&M’s share has plunged from 50% seven years ago to about 14% at present amid aggressive competition from Hyundai Motors India Ltd., Kia India Pvt. and Tata Motors Ltd. It has slipped to the fourth spot in the passenger vehicle segment.
Anish Shah, who recently took over as M&M’s chief executive officer, has set up a road map to revive growth. And the capex forecast offers a glimpse of the company’s focus for the next five years.
In the passenger vehicle business, the automaker will be spending Rs 9,000 crore towards strengthening its market share in the utility vehicle segment, more than a quarter of which will go towards developing electric vehicles,” Rajesh Jejurikar, executive director of auto and farm sectors at M&M, said on the analyst call. “We want to create a strong sophisticated SUV brand, and our endeavour will be to build a strong product portfolio,” Jejurikar said, adding that about nine launches are planned in the segment. The company will also spend to create a product portfolio in the electric vehicle segment and will scout for partnerships in areas of software, battery components, materials, among others.
The pipeline includes the five-door Thar, Scorpio, and the new Bolero which will be launched by 2026. Other launches such as XUV700, new XUV300 and SUVs codenamed W620 and V201, will also come with electric powertrain options. Besides, there will be two “born electric” or battery-powered models built from scratch that will debut in FY26.
The remaining Rs 3,000 crore will go towards the farm equipment sector to launch 14 new products across last-mile mobility, small commercial, and new urban pick-up ranges. The company will also invest to launch 37 new tractor models by 2026.
Additionally, M&M will invest Rs 5,000 crore in group companies and auto and farm subsidiaries. “These are directional investments, and if we don’t see a strong number of returns, we aren’t going to make it,” Shah said.
Mahindra & Mahindra Ltd. will spend Rs 12,000 crore in the next three years towards launching and upgrading a range of passenger and commercial vehicles as it seeks to regain lost market share.
The capex earmarked will fuel the company’s plan of launching 23 new products in commercial and passenger vehicle segments in the next five years, Chief Financial Officer Manoj Bhat said on a call with analysts on May 28 after the company announced quarterly earnings. Once a market leader in the SUV segment, M&M’s share has plunged from 50% seven years ago to about 14% at present amid aggressive competition from Hyundai Motors India Ltd., Kia India Pvt. and Tata Motors Ltd. It has slipped to the fourth spot in the passenger vehicle segment.
Anish Shah, who recently took over as M&M’s chief executive officer, has set up a road map to revive growth. And the capex forecast offers a glimpse of the company’s focus for the next five years.
In the passenger vehicle business, the automaker will be spending Rs 9,000 crore towards strengthening its market share in the utility vehicle segment, more than a quarter of which will go towards developing electric vehicles,” Rajesh Jejurikar, executive director of auto and farm sectors at M&M, said on the analyst call. “We want to create a strong sophisticated SUV brand, and our endeavour will be to build a strong product portfolio,” Jejurikar said, adding that about nine launches are planned in the segment. The company will also spend to create a product portfolio in the electric vehicle segment and will scout for partnerships in areas of software, battery components, materials, among others.
The pipeline includes the five-door Thar, Scorpio, and the new Bolero which will be launched by 2026. Other launches such as XUV700, new XUV300 and SUVs codenamed W620 and V201, will also come with electric powertrain options. Besides, there will be two “born electric” or battery-powered models built from scratch that will debut in FY26.
The remaining Rs 3,000 crore will go towards the farm equipment sector to launch 14 new products across last-mile mobility, small commercial, and new urban pick-up ranges. The company will also invest to launch 37 new tractor models by 2026.
Additionally, M&M will invest Rs 5,000 crore in group companies and auto and farm subsidiaries. “These are directional investments, and if we don’t see a strong number of returns, we aren’t going to make it,” Shah said.
TOWER TALK
May 29, 2021
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
May 29, 2021
*SBI* numbers beat the Street estimates as its EPS jumped from Rs. 4.01 to Rs. 7.21 in FY21. This share is a darling of the markets and must be added.
*Rishiroop* surprised analysts posting over 300% rise in Q4 EPS to Rs. 20.85 from Rs. 5.82 in Q4FY20. The FY21 EPS at nearly Rs. 51 makes this share a screaming buy!
*Hindalco’s* Q4 results of with EPS of Rs. 8.67 v/s Rs. 3.01 in Q4FY20 on the back of rising metal prices indicate of better times ahead for the Company. Add.
*An Ahmedabad based analyst recommends to buy Bector foods, Central Bank of India, Flex Foods, IOL Chemicals, Jindal Saw, Pudumjee Paper Products, Religare Enterprises, Reliance Power and Renuka Sugars.*
*B&A Ltd.* is available at an attractive valuation of just 4 times to its FY21E earnings. Apart from Tea it has packing business with its subsidary B&A Packing. The stock may give 50% returns within 1 year. Add.
*Emmessar Biotech*, a micro-cap fine chemicals co., presented good FY21 results with an EPS of Rs. 1.88 v/s Re. 1 last year. Its healthcare & nutritional products augur good future prospects. Around Rs. 25, it merits buying.
Mindboggling results by *Shree Cements* with Q4FY21 EPS of Rs. 302.75 v/s Rs. 270.11 last year and FY21 EPS of Rs. 971 makes it an excellent buy. Buy in small quantities.
*Panacea Biotec* has commenced production of the Russian Sputnik vaccine. The share price is slated to move up. Add.
*Ramco Cement’s* Q4 NP was up 51% to Rs. 218.6 cr. For FY21, it posted 29.7% higher consolidated net profit of Rs 783.60 cr. The company is in an expansion mode and its stock is set to rise. Add.
*Balkrishna Industries* presented good FY21 results as the EPS shot up from Rs. 49.64 to Rs. 60.91 on its Rs.2 FV share. This off- the-road tyre maker is a must for every portfolio.
*Polyplex Corporation’s* FY21 EPS of Rs. 162 and a final dividend of Rs17 takes the total to Rs. 164. With a share book value of over Rs.1500, the share is a bonus candidate yet available below BV. Two big expansions are on schedule. A screaming buy!
In line with the industry trend, *Indoco Remedies* posted FY21 EPS of Rs.10.10 v/s Rs. Rs. 2.62 last year. A good buy at current rates.
*Emami* posted a 285% surge in Q4 profit of Rs. 87 cr. The current trend shows an upward tick. Add.
Small sized *Anjani Portland Cement* posted superlative Q4 EPS of Rs. 9.56 v/s Rs. 3.18 last year. FY21 EPS at Rs.33.61 is more than double than last year’s Rs.15.96. Add.
Mid-size jeweler, *Goldiam International*, posted a higher top line and bottom line leading to FY21 EPS of Rs. 30.26 v/s Rs. 19.73 last year. The share may be added.
*Sun Pharmaceuticals’* Q4 NP surged from Rs. 124 cr to Rs. 894 cr on a 4.13% rise in revenue to Rs. 8522.98 cr. even as the company reduced debts by $ 580 mn. It spends nearly 7% of revenue on R&D and remains an investors’ favourite. Add.
*Alkyl Amines’* Q4 NP jumped 88% to Rs. 92.59 cr. from Rs. 49.2 cr. with a final dividend of Rs.6. It supplies amines and related chemicals to the pharma, agrochemical, rubber chemical & water treatment industries. Add.
In line with the industry trend, *Cadila* reported excellent Q4 results with PAT surging 73% to Rs. 679 cr. For FY21, the NP galloped 81% to Rs. 2133.6 cr. The company is on the verge of launching an anti-covid drug. A big buy.
*Dixon Technology’s* Q4 NP soared over 60% to Rs. 44.26 cr. This design focused product company has huge capex plans of about Rs. 500 cr. and will gain from the PLI scheme. Add.
*Rama Phosphates’* bumper Q4 PAT jumped to Rs 12.76cr from Rs. 2.50 cr. For FY21, NP soared from Rs. 17.67 cr to Rs. 42.11 cr. as the EPS jumped from Rs. 9.99 to Rs. 23.80. This year, will also benefit from newly added capacities. Buy immediately.
*HIL*, the maker of Charminar brand asbestos products posted FY21 EPS of Rs. 346.89 from Rs. 141.73 last year and will pay Rs. 40 as dividend. An excellent share to add.
*Jayant Organics’* Q4 EPS was fairly good at Rs. 6.48 v/s Rs. 2.52 and FY21 EPS of Rs. 11.20 v/s loss of Rs. 8.55 per share points to much better times ahead. Add.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Canara Bank* plans to raise Rs. 9000 cr. by way of equity and/or debt in order to augment its business and improve profitability. Add.
*Reliance Infra* from the ADAG group has posted standalone Q4 EPS of Rs. 4.87 and plans to turn debt free this year apart from a favorable judgment in the Delhi Metro case. Buy.
*Infibeam Avenues* posted a strong set of Q4 numbers. A good short-term pick. Buy.
*NFL* has gained over 20% in a month and is expected to rise further. Buy.
*Subex* has proven capital allocation skills fetching higher returns on lesser capital. Many analysts feel that it can be the next Tanla Platforms. Buy for multi-bagger returns.
*Lyka Lab* is one of the five companies roped in by the Central Government to manufacture the anti- fungal drug, Amphotericin-B, as the cases of Black fungus escalates in the country. Add.
Add *R-Power* has inducted a new management. Buy for 50% returns.
Majesco, a global leader of cloud insurance software solutions and Infosys, a global leader in next generation digital services and consulting jointly announced a strategic collaboration. Buy *Majesco* shares for 50% gain in the medium term.
*Dhunseri Ventures* having subsidiaries and joint ventures has chalked out a Rs.400 cr., 45,000 TPA polyester packaging plant has posted 9MFY21 consolidated EPS of Rs 32.6 is grossly underpriced. Its sound financials will take the share price to dizzy heights. Buy.
*IIFL Securities*, a key player in retail and institutional segments with 2500 offices across 500 cities continues to expand having acquired 11 lakh demat accounts from Karvy. It has notched 108% higher Q4FY21 EPS of Rs 2.4 and FY21 EPS of Rs 7, which may rise to Rs 12 in FY22. Buy for 50% gain.
The shift to organised security helped *Securities & Intelligence* post Q4FY21 EPS of Rs 6.9 and FY21 EPS of Rs 25, which may rise to Rs 35 in FY22 on the back of labour reforms, client preference to technology and the opening up of economies post-Covid. Buy for 30% gain.
*Anup Engineering* from the Sanjay Lalbhai Group caters to a wide range of process industries including Oil & Gas, Petrochemicals, LNG, Fertilizers, Chemicals/ Pharmaceuticals, Power, Water, Paper & Pulp and Aerospace has notched Q4FY21 EPS of Rs 27 and FY21 EPS of Rs 52.5, which could rise to an EPS of Rs 75 in FY22. Buy for 50% gain.
*Prima Plastics*, a competitor of Nilkamal Ltd., has notched 48% higher EPS of Rs 13.6 in FY21. Buy for 20% gain.
*Mangalam Cement* from the BK Birla group has notched 134% higher Q4 EPS of Rs 13.6 and 44% higher FY21 EPS of Rs 40.8, which may rise to Rs 50 in FY22 going by the strong demand for cement. A reasonable P/E of 10x can take its share price to Rs 400 in the medium term. Buy.
*Kaveri Seeds*, a leader in key crops with 8-10% of the Rs 15, 000 cr. organized hybrid seed market may notch FY21 EPS of Rs 60. Heavy investment buying is reported in the counter. A reasonable P/E of 14x can take its share price to Rs 840. Accumulate.
*Chennai Petroleum* has notched Q4FY21 EPS of Rs 16.3 in FY21 and Rs 17.3 in FY21 due to higher refinery margins. The share is likely to touch Rs 160 in the short term.
MNC *Ineos Styrolutions India* is undergoing an expanion and notched Q4FY21 EPS of Rs 92 and FY21 EPS of Rs 159. The robust demand from all sectors and strong margins could lead to FY22 EPS of Rs 200 and the share may double from the current level. Accumulate.
*Venus Remedies* manufactures a wide range of drugs for different therapeutic segments and analgesics and vitamins has notched 9MFY21 EPS of Rs 21.6 leading to FY21 EPS of Rs 30 and Rs 40 in FY22 and turn debt-free going forward. Buy for 30% gain.
*Ganesh Benzoplast*, manufacturer and exporter of food preservatives, lubricant Additives, API drugs, Sodium Benzoate, Benzoic Acid and Benzaldehyde etc. has notched 40% higher EPS of Rs 6.6 in 9MFY21, which could lead to FY21 EPS of Rs 9. Buy for 30% gain.
*Jindal SAW* declared highest ever quarterly sales and 461% higher net profit. It reduced debt in FY21 and interest cost fell to the lowest since FY14. This dark horse can give multi-bagger returns.
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 20
0 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
BS
Some positive announcement is likely from *Central Bank of India*. At Rs 19, it is a very good buy for decent returns in the short to medium term. Its results are due on 7th June.
Ethyl Acetate prices have zoomed in the last few months. Apart from Laxmi Organics and Jubilant Ingrevia, *IOL Chemicals & Pharmaceuticals* is one of its largest producer. Big HNI, Ashish Kacholia, has raised his stake to 7,50,000 shares in it and its results are due on 4th June. Add.
*Maheshwari Logistics* into Kraft papers, Logistics & Coal trade plans to set up a Plastic boiler at Valsad by March 22, which will be a game changer as it generates energy from plastic waste. A potential multi-bagger.
*Pennar Industries* manufactures Cold Rolled Steel Strips and Cold Formed Metal Profiles across six manufacturing plants and earns 12%+ EBITDA margin on a sustained basis. The stock can rise by 50%. Buy.
*Shemaroo* recommended last week soared from Rs.97 to Rs.180, HT Media from Rs.22 to Rs.30, RPSG Ventures from Rs.395 to Rs.469, HSIL from Rs.212 to Rs.248, 3i Infotech from Rs.8.8 to 9.7. Shemaroo has now corrected to Rs.150 and again looks good for investment for further upmove as the valuation gap with its peers plays out.
Vijay Mahnot, President of GreenPanel Industries (mktcap 3000cr+) has joined as CEO of Signet Industries (mktcap 100cr+), a small micro-cap co manufacturing PVC Pipes. Sources aver *Signet Industries* can give multifold returns from hereon.
Paytm plans an IPO worth Rs.25000cr. This may give a good fillip to *Digispice Technologies (SPICE MONEY wallet)* as it trades at a mktcap of just Rs.1000cr although the two stocks are not in the same league.
*Building material producers like Astral, Prince, Acrysil, are trading at valuations of 40x but HSIL (Hindustan Sanitary) trades below 15x. Noted investors like Ashish Dhawan, Sunil Singhania, Mukul Agarwal, Jitendra Parekh & few others have already taken big bets on this stock, which can double from hereon.*
*JK Tyre* has been gaining market share for two years but still trades at a PE multiple of less than 10x while Apollo Tyres trades at a multiple of 25x. Accumulate the JK stock at every decline for good gains in the medium to long term.
*Lemon Tree Hotels* gave a breakout at Rs.40. As the unlock phase starts, hotels will get bookings and occupancies will be sold out soon. Buy for a target of Rs.50
*Asian Tiles* has given a technical breakout at Rs. 20
0 with huge volumes and has even crossed the 100 DMA with ease. Buy with a target of Rs. 360.
BS
Supreme Petro CMP 746:
Supreme Petrochem is engaged in the business of Styrenics and manufactures Polystyrene (PS), Expandable Polystyrene (EPS), Masterbatches and Compounds of Styrenics and other Polymers, Extruded Polystyrene Insulation Board (XPS) Styrene Methyl Methacrylate (SMMA).
SPL is India’s largest producer of PS products. The annual installed capacity of PS, EPS, specialty polymers and compounds and extruded PS is 2,72,000MT, 72,100MT, 33,500MT and 5,000MT, respectively.
Financial
- ROE and ROCE is around 55% and 72% respectively. (Excellent)
- P/BV - 5.9x,, Face Value: INR 10.
- Forward PE - 15 which is average as per Industry benchmark.
- Q4FY21 topline was around INR 1,269 Cr Vs. 663 Cr in YoY Vs. 930 Cr in QoQ. Therfore up by 91% in YoY and 36% in YoY.
- FY21 topline: INR 3,185 Cr Vs. 2,724 Cr in FY20 up by 16.9% in YoY.
- Q4FY21 bottomline was around INR 232 Cr Vs. 24 Cr in YoY Vs. 172 Cr in QoQ therefore up by 866% in YoY and 35% in QoQ.
- FY21 bottomline was around INR 477 Cr Vs. 103 Cr in YoY therefore up by 363% in YoY.
- Debt free company.
- Operating profit margin is around 21% in FY21 which is highest in all the past years.
- Operating cash flow is also excellent and it was 435 Cr Vs. 120 Cr in YoY.
- Promoter holding is around 64% which is strong and stable and increased by more than 1.5% in last 1 year, FIIs and DIIs hold around 1.2% and 2.1% respectively.
Opportunities
- SPL is benefitting in the domestic market from the shutdown of the LG Polymers India Ltd's (second largest polystyrene (PS) manufacturer in India; accounting for close to 25% of India's PS capacity) facility post a styrene vapour leakage incident at its Vizag plant in May 2020. According to SPL’s management, in the absence of any planned capacity addition from the competitors, the demand-supply scenario has structurally improved in the domestic PS industry. To meet the supply gap created by LG Polymers' capacity shutdown, SPL is undertaking brownfield expansion for its PS capacity by 80,000MT and expandable polystyrene (EPS) capacity by 30,000MT.
- Strong EBITDA depsite Q1 was disturbed on account of lockdown.
- SPL plans to enter the mass acrylonitrile butadiene styrene (ABS) market, with an initial capacity of around 60,000tpa to 80,000tpa by setting up a new line at the existing plant over FY22-FY24. Improved PS capacity is likely to reduce the revenue share of VAP over the near term.
- The company continues to hold a leading position in the domestic PS (about 44% share of domestic supply including LG Polymers' capacity) and EPS markets. The company’s strong market position and large scale are likely to improve further with the completion of PS expansion project. It is the only domestic manufacturer of extruded PS foam board and styrene methyl methacrylate.
- Long term operating track record.
- Dividend is increasing trend and after strong performance company has paid around INR 12.5 per share as an dividend.
- Company has reserve of around 970 Crs.
Concern
- Volatility in polypropylene caps margin and volatility of SM prices also.
- Last 5 year topline growth was in single digit.
View Share high 820 and now 740. Share can considered a good investment in longer run any correction in price will give good opportunity to enter. Short term support 675 Target can be 900.
Views are shared just for educational purpose and personal in nature others can take different view/opinion.
Supreme Petrochem is engaged in the business of Styrenics and manufactures Polystyrene (PS), Expandable Polystyrene (EPS), Masterbatches and Compounds of Styrenics and other Polymers, Extruded Polystyrene Insulation Board (XPS) Styrene Methyl Methacrylate (SMMA).
SPL is India’s largest producer of PS products. The annual installed capacity of PS, EPS, specialty polymers and compounds and extruded PS is 2,72,000MT, 72,100MT, 33,500MT and 5,000MT, respectively.
Financial
- ROE and ROCE is around 55% and 72% respectively. (Excellent)
- P/BV - 5.9x,, Face Value: INR 10.
- Forward PE - 15 which is average as per Industry benchmark.
- Q4FY21 topline was around INR 1,269 Cr Vs. 663 Cr in YoY Vs. 930 Cr in QoQ. Therfore up by 91% in YoY and 36% in YoY.
- FY21 topline: INR 3,185 Cr Vs. 2,724 Cr in FY20 up by 16.9% in YoY.
- Q4FY21 bottomline was around INR 232 Cr Vs. 24 Cr in YoY Vs. 172 Cr in QoQ therefore up by 866% in YoY and 35% in QoQ.
- FY21 bottomline was around INR 477 Cr Vs. 103 Cr in YoY therefore up by 363% in YoY.
- Debt free company.
- Operating profit margin is around 21% in FY21 which is highest in all the past years.
- Operating cash flow is also excellent and it was 435 Cr Vs. 120 Cr in YoY.
- Promoter holding is around 64% which is strong and stable and increased by more than 1.5% in last 1 year, FIIs and DIIs hold around 1.2% and 2.1% respectively.
Opportunities
- SPL is benefitting in the domestic market from the shutdown of the LG Polymers India Ltd's (second largest polystyrene (PS) manufacturer in India; accounting for close to 25% of India's PS capacity) facility post a styrene vapour leakage incident at its Vizag plant in May 2020. According to SPL’s management, in the absence of any planned capacity addition from the competitors, the demand-supply scenario has structurally improved in the domestic PS industry. To meet the supply gap created by LG Polymers' capacity shutdown, SPL is undertaking brownfield expansion for its PS capacity by 80,000MT and expandable polystyrene (EPS) capacity by 30,000MT.
- Strong EBITDA depsite Q1 was disturbed on account of lockdown.
- SPL plans to enter the mass acrylonitrile butadiene styrene (ABS) market, with an initial capacity of around 60,000tpa to 80,000tpa by setting up a new line at the existing plant over FY22-FY24. Improved PS capacity is likely to reduce the revenue share of VAP over the near term.
- The company continues to hold a leading position in the domestic PS (about 44% share of domestic supply including LG Polymers' capacity) and EPS markets. The company’s strong market position and large scale are likely to improve further with the completion of PS expansion project. It is the only domestic manufacturer of extruded PS foam board and styrene methyl methacrylate.
- Long term operating track record.
- Dividend is increasing trend and after strong performance company has paid around INR 12.5 per share as an dividend.
- Company has reserve of around 970 Crs.
Concern
- Volatility in polypropylene caps margin and volatility of SM prices also.
- Last 5 year topline growth was in single digit.
View Share high 820 and now 740. Share can considered a good investment in longer run any correction in price will give good opportunity to enter. Short term support 675 Target can be 900.
Views are shared just for educational purpose and personal in nature others can take different view/opinion.
*WEEKLY F&O REPORT 29-MAY-2021*
Hello,
How are you doing, stay safe.
Sharing F&O stock and index activity of last week and some of our viewpoints.
*NIFTY FUT @ 15463:- Bullish Trend until unless close/sustain below 15100*
*Technical & Data Viewpoints*
*>>>*Index broke multiple resistance levels & the previous week high as well as managed to close above Daily / Weekly & monthly Pivot points ( 15461 / 15141 & 15368 respectively). Swing average high is 15218 But 60 RSI breakout level is at 15060-15088.
*>> Hold long With sl of 15100 for upside 15777 (Buy on dips good level for buy 15222-15300 range)*
*>>* Look good to sell below 14935 With sl of 15135 for down side 14533*
*>>* Moving Averages:- 15244.9 (5-D), 14906.85 (21-D), 14795.15 (50-D), 14687.05 (100-D), 13343.45 (200-D).
*>>* RSI at 65.93 & Swing RSI level @ 14979.65
*>>* Trading range for month 14531.65 to 15777.7
*>>* Support at 14799.5 followed by 14531.65
*>>* Resistance at 15630.2 followed by 15777.7
*Future*
*>>* Last five trading session future open interest Decreased by -1.06 mn shares (-9.54%) & stock price up by 1.69%, Position Short Covering
*>>* Today future open interest Increased by 0.64 mn shares (5.76%) & stock price up by 0.5%, Position Long Buildup
*Beginning of months*
*>>* Apr21 Expiry till date stock price Increased by 5.3%.& Open interest Decreased by -21.77%.
*>>* Mar21 Expiry till date stock price Increased by 6.65%.& Open interest Decreased by -8.37%.
*>>* Feb21 Expiry till date stock price Increased by 1.9%.& Open interest Decreased by -20.15%.
*Option DATA*
*>>* Implied current @ 15.07%.
*>>*All Expiry PCR @ 1.32
*>>* Puts OI of 33458 lots value of 3880 (cr).
*>>* Calls OI of 237488 lots value of 27544 (cr).
*Today activities*
*>>* *Addition* 16000 Call 7663 lots. / 15000 Put 5589 lots.
*>>* *Deduction* 15000 Call -1618 lots. / 14200 Put -1132 lots.
*Highest Open Interest*
*>>* 16000 Calls Carrying Highest OI of (33458 lots), Followed by 15500 (20864 lots) & 15800 (14999 lots).
*>>* 14000 Puts Carrying Highest OI of (37244 lots), Followed by 14500 (36395 lots) & 13500 (30376 lots).
---------------------------------------------------------------------------------------------------
*BANKNIFTY FUT @ 35321.8 - Bullish Trend until unless close/sustain below 34500*
*Technical & Data Viewpoints*
*>>* Index close bove weekly and monthly pivot levels 34403 & 35080. Average swing high stand at 34667 all this level shows strong multiple resistance in between 34300-34500 range, for upside 36560.
*>> Hold long With sl of 34300 for upside 36560 (Buy on dips good level for buy 34900-35000 range)*
*>>* Look good to sell below 34300 With sl of 34900 for down side 33555 / 32915*
*>>* Moving Averages:- 34759.95 (5-D), 33474.75 (21-D), 33404.05 (50-D), 33505.7 (100-D), 29231.85 (200-D).
*>>* RSI at 64.09 & Swing RSI level @ 33555.25
*>>* Trading range for month 31537.6 to 37125
*>>* Support at 32705.9 followed by 31537.6
*>>* Resistance at 36430.85 followed by 37125
*Future*
*>>* Last five trading session future open interest Decreased by -0.14 mn shares (-7.73%) & stock price up by 0.92%, Position Short Covering
*>>* Today future open interest Increased by 0.03 mn shares (1.66%) & stock price up by 0.04%, Position Long Buildup
*Beginning of months*
*>>* Apr21 Expiry till date stock price Increased by 7.3%.& Open interest Decreased by -28.71%.
*>>* Mar21 Expiry till date stock price Increased by 5.69%.& Open interest Decreased by -85.03%.
*>>* Feb21 Expiry till date stock price Decreased by -3.96%.& Open interest Increased by 0.55%.
*Option DATA*
*>>* Implied current @ 25%
*>>*All Expiry PCR @ 0.75
*>>* Puts OI of 14933 lots value of 1319 (cr).
*>>* Calls OI of 110567 lots value of 9764 (cr).
*Today activities*
*>>* *Addition* 36000 Call 4649 lots. / 33000 Put 4145 lots.
*>>* *Deduction* 37000 Call -4040 lots. / 35000 Put -154 lots.
Hello,
How are you doing, stay safe.
Sharing F&O stock and index activity of last week and some of our viewpoints.
*NIFTY FUT @ 15463:- Bullish Trend until unless close/sustain below 15100*
*Technical & Data Viewpoints*
*>>>*Index broke multiple resistance levels & the previous week high as well as managed to close above Daily / Weekly & monthly Pivot points ( 15461 / 15141 & 15368 respectively). Swing average high is 15218 But 60 RSI breakout level is at 15060-15088.
*>> Hold long With sl of 15100 for upside 15777 (Buy on dips good level for buy 15222-15300 range)*
*>>* Look good to sell below 14935 With sl of 15135 for down side 14533*
*>>* Moving Averages:- 15244.9 (5-D), 14906.85 (21-D), 14795.15 (50-D), 14687.05 (100-D), 13343.45 (200-D).
*>>* RSI at 65.93 & Swing RSI level @ 14979.65
*>>* Trading range for month 14531.65 to 15777.7
*>>* Support at 14799.5 followed by 14531.65
*>>* Resistance at 15630.2 followed by 15777.7
*Future*
*>>* Last five trading session future open interest Decreased by -1.06 mn shares (-9.54%) & stock price up by 1.69%, Position Short Covering
*>>* Today future open interest Increased by 0.64 mn shares (5.76%) & stock price up by 0.5%, Position Long Buildup
*Beginning of months*
*>>* Apr21 Expiry till date stock price Increased by 5.3%.& Open interest Decreased by -21.77%.
*>>* Mar21 Expiry till date stock price Increased by 6.65%.& Open interest Decreased by -8.37%.
*>>* Feb21 Expiry till date stock price Increased by 1.9%.& Open interest Decreased by -20.15%.
*Option DATA*
*>>* Implied current @ 15.07%.
*>>*All Expiry PCR @ 1.32
*>>* Puts OI of 33458 lots value of 3880 (cr).
*>>* Calls OI of 237488 lots value of 27544 (cr).
*Today activities*
*>>* *Addition* 16000 Call 7663 lots. / 15000 Put 5589 lots.
*>>* *Deduction* 15000 Call -1618 lots. / 14200 Put -1132 lots.
*Highest Open Interest*
*>>* 16000 Calls Carrying Highest OI of (33458 lots), Followed by 15500 (20864 lots) & 15800 (14999 lots).
*>>* 14000 Puts Carrying Highest OI of (37244 lots), Followed by 14500 (36395 lots) & 13500 (30376 lots).
---------------------------------------------------------------------------------------------------
*BANKNIFTY FUT @ 35321.8 - Bullish Trend until unless close/sustain below 34500*
*Technical & Data Viewpoints*
*>>* Index close bove weekly and monthly pivot levels 34403 & 35080. Average swing high stand at 34667 all this level shows strong multiple resistance in between 34300-34500 range, for upside 36560.
*>> Hold long With sl of 34300 for upside 36560 (Buy on dips good level for buy 34900-35000 range)*
*>>* Look good to sell below 34300 With sl of 34900 for down side 33555 / 32915*
*>>* Moving Averages:- 34759.95 (5-D), 33474.75 (21-D), 33404.05 (50-D), 33505.7 (100-D), 29231.85 (200-D).
*>>* RSI at 64.09 & Swing RSI level @ 33555.25
*>>* Trading range for month 31537.6 to 37125
*>>* Support at 32705.9 followed by 31537.6
*>>* Resistance at 36430.85 followed by 37125
*Future*
*>>* Last five trading session future open interest Decreased by -0.14 mn shares (-7.73%) & stock price up by 0.92%, Position Short Covering
*>>* Today future open interest Increased by 0.03 mn shares (1.66%) & stock price up by 0.04%, Position Long Buildup
*Beginning of months*
*>>* Apr21 Expiry till date stock price Increased by 7.3%.& Open interest Decreased by -28.71%.
*>>* Mar21 Expiry till date stock price Increased by 5.69%.& Open interest Decreased by -85.03%.
*>>* Feb21 Expiry till date stock price Decreased by -3.96%.& Open interest Increased by 0.55%.
*Option DATA*
*>>* Implied current @ 25%
*>>*All Expiry PCR @ 0.75
*>>* Puts OI of 14933 lots value of 1319 (cr).
*>>* Calls OI of 110567 lots value of 9764 (cr).
*Today activities*
*>>* *Addition* 36000 Call 4649 lots. / 33000 Put 4145 lots.
*>>* *Deduction* 37000 Call -4040 lots. / 35000 Put -154 lots.
*Highest Open Interest*
*>>* 40000 Calls Carrying Highest OI of (14933 lots), Followed by 36000 (12828 lots) & 35000 (11337 lots).
*>>* 33000 Puts Carrying Highest OI of (16700 lots), Followed by 34000 (9405 lots) & 35000 (8691 lots).
---------------------------------------------------------------------------------------------------
*Participant wise Open Interest (in lots) :-NET POSITION*
*INDEX FUTURE*
*FII* 92162 (Long) v/s 44144 (Long), *RETAIL* -36268 (Short) v/s 1494 (Long), *PRO* -13089 (Short) v/s -5142 (short), *DII* -42805 (Short) v/s -40496 (short),
*(V/S = 5 Days Average)*
*STOCK FUTURE*
*FII* 25048 (Long) *RETAIL* 898619 (Long) *PRO* 128268 (Long) *DII* -1051935 (Short)
*INDEX CALL*
*FII* 96888 (Long) *RETAIL* -54410 (Short) *PRO* -42745 (Short) *DII* 267 (Long)
*INDEX PUT*
*FII* 131100 (Long) *RETAIL* -152950 (Short) *PRO* -23950 (Short) *DII* 45800 (Long)
*Holding Index Future + Option Delta= NET FUTURE*
*FII* 87987 (Long), *RETAIL* -21399 (Short), *PRO* -16597 (Short), *DII* -49990 (Short),
Call / Put Delta
Average Call Delta = 0.18 v/s 0.26
Average Put Delta = -0.15 v/s -0.21
---------------------------------------------------------------------------------------------------
*Week on week*
*Top 5 Gainers*
CONCOR stock up by 12.47%,*Position* Short Covering
ZEEL stock up by 10.16%,*Position* Long Buildup
PNB stock up by 10.12%,*Position* Short Covering
MINDTREE stock up by 10.02%,*Position* Short Covering
LTI stock up by 7.26%,*Position* Short Covering
*Top 5 Losses*
BEL stock down by -7.92%,*Position* Short Buildup
CHOLAFIN stock down by -6.64%,*Position* Short Buildup
TORNTPOWER stock down by -6.53%,*Position* Long Unwinding
AMARAJABAT stock down by -6.34%,*Position* Short Buildup
CUMMINSIND stock down by -5.05%,*Position* Short Buildup
*Top 5 stock Open interest increased and decreased WOW*"
*Increased*
*AMARAJABAT* close at 743.75, OI 34.54%, (3.16mn shares, (Value of 235 cr) added, Position Short Buildup
*CUMMINSIND* close at 791.05, OI 33.09%, (0.92mn shares, (Value of 73 cr) added, Position Short Buildup
*CHOLAFIN* close at 544.05, OI 27.31%, (2.83mn shares, (Value of 154 cr) added, Position Short Buildup
*BEL* close at 144.85, OI 27.22%, (10.88mn shares, (Value of 158 cr) added, Position Short Buildup
*ESCORTS* close at 1162.35, OI 21.3%, (0.93mn shares, (Value of 108 cr) added, Position Long Buildup
*Decreased*
*COFORGE* close at 3543.05, OI -60.93%, (-0.65mn shares, (Value of -230 cr) reduced, Position Short Covering
*TORNTPOWER* close at 429.25, OI -53.71%, (-1.07mn shares, (Value of -46 cr) reduced, Position Long Unwinding
*GMRINFRA* close at 26.15, OI -50.88%, (-46.1mn shares, (Value of -121 cr) reduced, Position Long Unwinding
*SBILIFE* close at 976.85, OI -43.8%, (-2.46mn shares, (Value of -240 cr) reduced, Position Short Covering
*NAVINFLUOR* close at 3213.35, OI -42.46%, (-0.12mn shares, (Value of -39 cr) reduced, Position Short Covering
*Future open interest compared with series Open (Increased) :-* CANBK, NAM-INDIA, UBL, TRENT, SRTRANSFIN, RELIANCE, SUNTV, LICHSGFIN
*OI in Value cr*
CANBK: 888.23 v/s 677.7, *Position* Short Covering
NAM-INDIA: 45.26 v/s 37.79, *Position* Short Buildup
UBL: 138.37 v/s 113.21, *Position* Short Buildup
TRENT: 77.32 v/s 66.16, *Position* Short Covering
SRTRANSFIN: 488.18 v/s 428.43, *Position* Long Unwinding
RELIANCE: 6589.98 v/s 6086.18, *Position* Long Buildup
SUNTV: 846.08 v/s 753.41, *Position* Long Buildup
LICHSGFIN: 282.99 v/s 253.82, *Position* Long Buildup
HDFCAMC: 163.25 v/s 151.86, *Position* Short Covering
AMARAJABAT: 683.68 v/s 625.27, *Position* Short Buildup
*Future open interest compared with series Open (Decreased):-* SUNPHARMA, EICHERMOT, SHREECEM, NESTLEIND, BPCL, LTI, CHOLAFIN, ALKEM
*OI in Value cr*
SUNPHARMA: 3078.9 v/s 2956.27, *Position* Long Unwinding
*>>* 40000 Calls Carrying Highest OI of (14933 lots), Followed by 36000 (12828 lots) & 35000 (11337 lots).
*>>* 33000 Puts Carrying Highest OI of (16700 lots), Followed by 34000 (9405 lots) & 35000 (8691 lots).
---------------------------------------------------------------------------------------------------
*Participant wise Open Interest (in lots) :-NET POSITION*
*INDEX FUTURE*
*FII* 92162 (Long) v/s 44144 (Long), *RETAIL* -36268 (Short) v/s 1494 (Long), *PRO* -13089 (Short) v/s -5142 (short), *DII* -42805 (Short) v/s -40496 (short),
*(V/S = 5 Days Average)*
*STOCK FUTURE*
*FII* 25048 (Long) *RETAIL* 898619 (Long) *PRO* 128268 (Long) *DII* -1051935 (Short)
*INDEX CALL*
*FII* 96888 (Long) *RETAIL* -54410 (Short) *PRO* -42745 (Short) *DII* 267 (Long)
*INDEX PUT*
*FII* 131100 (Long) *RETAIL* -152950 (Short) *PRO* -23950 (Short) *DII* 45800 (Long)
*Holding Index Future + Option Delta= NET FUTURE*
*FII* 87987 (Long), *RETAIL* -21399 (Short), *PRO* -16597 (Short), *DII* -49990 (Short),
Call / Put Delta
Average Call Delta = 0.18 v/s 0.26
Average Put Delta = -0.15 v/s -0.21
---------------------------------------------------------------------------------------------------
*Week on week*
*Top 5 Gainers*
CONCOR stock up by 12.47%,*Position* Short Covering
ZEEL stock up by 10.16%,*Position* Long Buildup
PNB stock up by 10.12%,*Position* Short Covering
MINDTREE stock up by 10.02%,*Position* Short Covering
LTI stock up by 7.26%,*Position* Short Covering
*Top 5 Losses*
BEL stock down by -7.92%,*Position* Short Buildup
CHOLAFIN stock down by -6.64%,*Position* Short Buildup
TORNTPOWER stock down by -6.53%,*Position* Long Unwinding
AMARAJABAT stock down by -6.34%,*Position* Short Buildup
CUMMINSIND stock down by -5.05%,*Position* Short Buildup
*Top 5 stock Open interest increased and decreased WOW*"
*Increased*
*AMARAJABAT* close at 743.75, OI 34.54%, (3.16mn shares, (Value of 235 cr) added, Position Short Buildup
*CUMMINSIND* close at 791.05, OI 33.09%, (0.92mn shares, (Value of 73 cr) added, Position Short Buildup
*CHOLAFIN* close at 544.05, OI 27.31%, (2.83mn shares, (Value of 154 cr) added, Position Short Buildup
*BEL* close at 144.85, OI 27.22%, (10.88mn shares, (Value of 158 cr) added, Position Short Buildup
*ESCORTS* close at 1162.35, OI 21.3%, (0.93mn shares, (Value of 108 cr) added, Position Long Buildup
*Decreased*
*COFORGE* close at 3543.05, OI -60.93%, (-0.65mn shares, (Value of -230 cr) reduced, Position Short Covering
*TORNTPOWER* close at 429.25, OI -53.71%, (-1.07mn shares, (Value of -46 cr) reduced, Position Long Unwinding
*GMRINFRA* close at 26.15, OI -50.88%, (-46.1mn shares, (Value of -121 cr) reduced, Position Long Unwinding
*SBILIFE* close at 976.85, OI -43.8%, (-2.46mn shares, (Value of -240 cr) reduced, Position Short Covering
*NAVINFLUOR* close at 3213.35, OI -42.46%, (-0.12mn shares, (Value of -39 cr) reduced, Position Short Covering
*Future open interest compared with series Open (Increased) :-* CANBK, NAM-INDIA, UBL, TRENT, SRTRANSFIN, RELIANCE, SUNTV, LICHSGFIN
*OI in Value cr*
CANBK: 888.23 v/s 677.7, *Position* Short Covering
NAM-INDIA: 45.26 v/s 37.79, *Position* Short Buildup
UBL: 138.37 v/s 113.21, *Position* Short Buildup
TRENT: 77.32 v/s 66.16, *Position* Short Covering
SRTRANSFIN: 488.18 v/s 428.43, *Position* Long Unwinding
RELIANCE: 6589.98 v/s 6086.18, *Position* Long Buildup
SUNTV: 846.08 v/s 753.41, *Position* Long Buildup
LICHSGFIN: 282.99 v/s 253.82, *Position* Long Buildup
HDFCAMC: 163.25 v/s 151.86, *Position* Short Covering
AMARAJABAT: 683.68 v/s 625.27, *Position* Short Buildup
*Future open interest compared with series Open (Decreased):-* SUNPHARMA, EICHERMOT, SHREECEM, NESTLEIND, BPCL, LTI, CHOLAFIN, ALKEM
*OI in Value cr*
SUNPHARMA: 3078.9 v/s 2956.27, *Position* Long Unwinding